vasotocin has been researched along with Disease Models, Animal in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Khobets, V; Tkachenko, N; Tral, T; Yarmolinskaya, M | 1 |
| Cao, L; Eisenried, A; Klukinov, M; Meidahl, AC; Tzabazis, AZ; Yeomans, DC | 1 |
| Samson, WK; Yosten, GL | 1 |
| Dehpour, AR; Ejtemaei Mehr, S; Fakhfouri, G; Khodagholi, F; Khoshneviszadeh, M; Payandemehr, B; Rahimian, R | 1 |
| Bulayeva, N; Chiossi, G; Godin, B; Gorenstein, D; Leonard, F; Longo, M; Ontiveros, A; Refuerzo, JS | 1 |
| Amini-Khoei, H; Amiri, S; Dehpour, AR; Haj-Mirzaian, A; Hassanipour, M; Hosseini, MJ; Mehr, SE; Mirzaian, AH; Mohammadi-Asl, A; Momeny, M; Rastegar, M; Sanjarimoghaddam, H | 1 |
| Matsui, H; Matsushita, H; Nishiki, T; Ohmori, I; Okimoto, N; Tomizawa, K | 1 |
| Danalache, B; Gangal, M; Gutkowska, J; Jankowski, M; Wang, D | 1 |
| Ertmer, C; Lange, M; Morelli, A; Rehberg, S; Schneider, M; Traber, DL; Van Aken, H; Vincent, JL; Westphal, M | 1 |
| Dünser, MW | 1 |
| Aydin, NE; Celik, O; Colak, C; Gul, M; Karaer, A; Koc, O; Simsek, Y; Yılmaz, E; Zengin, S | 1 |
| Bartha, E; Cox, RA; Enkhbaatar, P; Hasselbach, AK; Jonkam, C; Rehberg, S; Sousse, L; Traber, DL; Traber, LD; Westphal, M; Yamamoto, Y | 1 |
| Eisenach, JC; Gutierrez, S; Hayashida, K; Houle, TT; Liu, B | 1 |
| Goldman, MB; Mitchell, CP | 1 |
| Bee, WH; Chellman, GJ; Haluska, GJ; Meyer, JK; Reinheimer, TM; Resendez, JC | 1 |
| Reinheimer, TM | 1 |
| Abraham, BK; Asad, M; Koumaravelou, K; Ramaswamy, S; Shewade, DG; Vasu, S | 1 |
| Capetola, RJ; Demarest, KT; Ericson, E; Hahn, DW; Homm, RE; McGuire, JL | 1 |
18 other study(ies) available for vasotocin and Disease Models, Animal
| Article | Year |
|---|---|
The potentialities of oxytocin receptor inhibitors for endometriosis therapy.
Topics: Adolescent; Adult; Animals; Case-Control Studies; Disease Models, Animal; Drug Evaluation, Preclinical; Endometriosis; Female; Humans; Middle Aged; Molecular Targeted Therapy; Oxytocin; Pelvic Pain; Peritoneal Diseases; Rats; Rats, Wistar; Receptors, Oxytocin; Syndrome; Vasotocin; Young Adult | 2020 |
Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury.
Topics: Administration, Intranasal; Administration, Intravenous; Animals; Behavior, Animal; Brain Concussion; Chronic Pain; Disease Models, Animal; Facial Pain; Hormone Antagonists; Hyperalgesia; Male; Oxytocin; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Vasotocin | 2018 |
Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin.
Topics: alpha-MSH; Animals; Blood Pressure; Calcium-Binding Proteins; Corticotropin-Releasing Hormone; Disease Models, Animal; DNA-Binding Proteins; Hormones; Hypertension; Male; Melanocortins; Melanocyte-Stimulating Hormones; Nerve Net; Nerve Tissue Proteins; Nucleobindins; Oxytocin; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Oxytocin; Vasotocin | 2014 |
Oxytocin is involved in the proconvulsant effects of Sildenafil: Possible role of CREB.
Topics: Animals; CREB-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Hormone Antagonists; Male; Mice; Oxytocin; Pentylenetetrazole; Phosphodiesterase 5 Inhibitors; Phosphorylation; Receptors, Oxytocin; Seizures; Signal Transduction; Sildenafil Citrate; Time Factors; Vasotocin | 2016 |
Uterus-targeted liposomes for preterm labor management: studies in pregnant mice.
Topics: Animals; Disease Models, Animal; Drug Compounding; Female; Gene Expression; Hormone Antagonists; Humans; Indomethacin; Liposomes; Mice; Molecular Targeted Therapy; Nanostructures; Obstetric Labor, Premature; Placenta; Pregnancy; Premature Birth; Protein Binding; Receptors, Oxytocin; Tocolytic Agents; Uterine Contraction; Uterus; Vasotocin | 2016 |
Oxytocin mitigated the depressive-like behaviors of maternal separation stress through modulating mitochondrial function and neuroinflammation.
Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Hippocampus; Hormone Antagonists; Inflammation; Male; Maternal Deprivation; Mice; Mitochondrial Diseases; Oxytocin; Vasotocin | 2017 |
Oxytocin mediates the antidepressant effects of mating behavior in male mice.
Topics: Animals; Depression; Disease Models, Animal; Female; Freezing Reaction, Cataleptic; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxytocin; Receptors, Oxytocin; Sexual Behavior, Animal; Swimming; Vasotocin | 2010 |
Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fibrosis; Fulvestrant; Genistein; Hypertension; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; Ovariectomy; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; RNA, Messenger; Vasotocin; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
Role of selective V1a receptor agonism in ovine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Disease Models, Animal; Female; Hemodynamics; Immunohistochemistry; Kaplan-Meier Estimate; Norepinephrine; Oxygen Consumption; Pulmonary Gas Exchange; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin | 2011 |
Mirror, mirror on the wall: Which is the best vasopressin receptor of them all?
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hemodynamics; Humans; Norepinephrine; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin | 2011 |
Therapeutic efficiency of Atosiban, an oxytocin receptor blocking agent in the treatment of experimental endometriosis.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Disease Models, Animal; Endometriosis; Female; Hormone Antagonists; Humans; Rats; Rats, Wistar; Receptors, Oxytocin; Vasotocin | 2012 |
Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis.
Topics: Angiopoietin-2; Animals; Arginine Vasopressin; Arterial Pressure; Blood Vessels; Capillary Permeability; Disease Models, Animal; Female; Hemodynamics; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Neutrophil Infiltration; Nitric Oxide; Pneumonia, Staphylococcal; Receptors, Vasopressin; Sepsis; Sheep; Smoke Inhalation Injury; Time Factors; Tyrosine; Vascular Endothelial Growth Factor A; Vasoconstriction; Vasoconstrictor Agents; Vasotocin; Ventricular Function, Left | 2012 |
Reversal of peripheral nerve injury-induced hypersensitivity in the postpartum period: role of spinal oxytocin.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Hormone Antagonists; Hypersensitivity; Injections, Spinal; Naloxone; Narcotic Antagonists; Oxytocics; Oxytocin; Peripheral Nerve Injuries; Physical Stimulation; Postpartum Period; Rats; Rats, Sprague-Dawley; Spinal Nerves; Vasotocin; Weaning | 2013 |
Neonatal lesions of the ventral hippocampal formation disrupt neuroendocrine responses to auditory stress in the adult rat.
Topics: Acoustic Stimulation; Adrenocorticotropic Hormone; Age Factors; Animals; Animals, Newborn; Corticosterone; Disease Models, Animal; Hippocampus; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Stress, Psychological; Vasotocin | 2004 |
Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Macaca fascicularis; Obstetric Labor, Premature; Oxytocin; Pregnancy; Tocolytic Agents; Uterine Contraction; Vasotocin | 2005 |
Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Macaca fascicularis; Myometrium; Obstetric Labor, Premature; Oligopeptides; Pregnancy; Receptors, Oxytocin; Telemetry; Tocolytic Agents; Uterine Contraction; Vasotocin | 2007 |
Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
Topics: Acetic Acid; Acute Disease; Animals; Anti-Ulcer Agents; Chronic Disease; Cysteamine; Disease Models, Animal; Duodenal Ulcer; Duodenum; Ethanol; Female; Gastric Acid; Gastric Mucosa; Guinea Pigs; Histamine; Indomethacin; Male; Oxytocin; Pylorus; Ranitidine; Rats; Rats, Wistar; Stomach; Stomach Ulcer; Vasotocin | 2001 |
Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist, in animal models of uterine contractility and preterm labor: a new tocolytic agent.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Guinea Pigs; In Vitro Techniques; Obstetric Labor, Premature; Oxytocin; Pregnancy; Rats; Rats, Inbred Strains; Uterine Contraction; Vasotocin | 1987 |